HBV variants create “altered peptide ligands” which results in altered CD4+ T-cell function

1998 ◽  
Vol 28 ◽  
pp. 50
Author(s):  
M.-C. Jung ◽  
J.T. Gerlach ◽  
T. Santantonio ◽  
H. Diepolder ◽  
E. Wierenga ◽  
...  
2003 ◽  
Vol 198 (1) ◽  
pp. 99-109 ◽  
Author(s):  
Dong-Gyun Lim ◽  
Jacqueline M. Slavik ◽  
Katarzyna Bourcier ◽  
Kathrine J. Smith ◽  
David A. Hafler

T cell receptors recognize small changes in peptide ligands leading to different T cell responses. Here, we analyzed a panel of HLA-A2–Tax11-19 reactive T cell clones to examine how small allelic variations of MHC molecules could alter the functional outcome of antigen recognition. Similar to the effects induced by antigenic altered peptide ligands, weak or partial agonistic T cell functions were identified in individual T cell clones with the recognition of MHC-altered peptide ligands (MAPLs). Interestingly, one subtype of HLA-A2 molecules induced an unusual type of partial agonistic function; proliferation without cytotoxicity. Modeling of crystallographic data indicated that polymorphic amino acids in the HLA-A2 peptide binding groove, especially the D-pocket, were responsible for this partial agonism. Reciprocal mutations of the Tax peptide side chain engaging the D-pocket indeed restored the agonist functions of the MHC–peptide complex. Whereas early intracellular signaling events were not efficiently induced by these MAPLs, phosphorylated c-Jun slowly accumulated with sustained long-term expression. These data indicate that MAPLs can induce atypical partial agonistic T cell function through structural and biochemical mechanisms similar to altered peptide ligands.


2021 ◽  
pp. 103290
Author(s):  
Lanting Chen ◽  
Mengdie Li ◽  
Fengrun Sun ◽  
Jinfeng Qian ◽  
Meirong Du ◽  
...  

2007 ◽  
Vol 13 (7) ◽  
pp. 2158-2167 ◽  
Author(s):  
Peter E. Fecci ◽  
Hidenobu Ochiai ◽  
Duane A. Mitchell ◽  
Peter M. Grossi ◽  
Alison E. Sweeney ◽  
...  

Retrovirology ◽  
2014 ◽  
Vol 11 (1) ◽  
pp. 57 ◽  
Author(s):  
Evan S Jacobs ◽  
Desmond Persad ◽  
Longsi Ran ◽  
Ali Danesh ◽  
John W Heitman ◽  
...  

EBioMedicine ◽  
2019 ◽  
Vol 47 ◽  
pp. 427-435 ◽  
Author(s):  
Raquel Filipa Freitas ◽  
Afonso Basto ◽  
Silvia C.P. Almeida ◽  
Rita F. Santos ◽  
Carine M. Gonçalves ◽  
...  

2015 ◽  
Vol 45 (3) ◽  
pp. 829-842 ◽  
Author(s):  
Jinyu Zhang ◽  
Patricia Vandevenne ◽  
Haifa Hamdi ◽  
Merry Van Puyvelde ◽  
Alessandro Zucchi ◽  
...  

2004 ◽  
Vol 39 (Supplement 1) ◽  
pp. S119-S120
Author(s):  
M. S. Longhi ◽  
Y. Ma ◽  
D. P. Bogdanos ◽  
G. Mieli-Vergani ◽  
D. Vergani

PLoS Medicine ◽  
2007 ◽  
Vol 4 (3) ◽  
pp. e96 ◽  
Author(s):  
Olivier Gasser ◽  
Florian K Bihl ◽  
Marcel Wolbers ◽  
Elisabetta Loggi ◽  
Ingrid Steffen ◽  
...  

2000 ◽  
Vol 182 (2) ◽  
pp. 435-441 ◽  
Author(s):  
Ilana Fogelman ◽  
Victoria Davey ◽  
Hans D. Ochs ◽  
Michael Elashoff ◽  
Mark B. Feinberg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document